DESTINY-Breast09

Advertisement

cGxPJobs Banner

Daiichi Sankyo and AstraZeneca Win CHMP Backing for Enhertu in HER2-Positive Breast Cancer

Tokyo, July 24, 2026 Daiichi Sankyo and AstraZeneca announced that the European Medicines Agency’s Committee for Medicinal Products for...

By cGxPwire Editor
July 25, 2026

Read More

AstraZeneca Unveils Major ASCO 2026 Cancer and Rare Disease Data

CAMBRIDGE, UK, 22 May 2026 AstraZeneca announced a major scientific showcase at the upcoming ASCO Annual Meeting 2026, highlighting...

By cGxPwire Editor
May 23, 2026

Read More

Advertisement

cGxPJobs

Directory